Keyin Smart Medicine - Let precision medicine illuminate the future of human health

Based on the research frontier of microbiome and immune regulation, the company has built a dual-core driving technology platform of "multi-omics big data +AI intelligent medicine", deeply integrating the core technologies in the three fields of biological information, artificial intelligence and clinical medicine, focusing on early screening of inflammatory bowel disease (IBD), microbial detection - accurate evaluation and effective intervention of immune system. To provide global users with a full chain of solutions from risk warning to personalized health management.

With the "detection-intervention-tracking closed-loop system", Keine realizes real-time optimization iteration of health management solutions through artificial intelligence medical systems. In the future, we will continue to deepen precision medical innovation, promote health management from passive treatment to active prevention, uphold the mission of "for the people", and create sustainable value for the improvement of human life quality.